[Preference policy for levothyroxine: switch between brands may lead to symptoms and extra costs].

MLA

Willems, Jeresa I. A., et al. “[Preference Policy for Levothyroxine: Switch between Brands May Lead to Symptoms and Extra Costs].” Nederlands Tijdschrift Voor Geneeskunde, vol. 166, Feb. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=35138748&authtype=sso&custid=ns315887.

APA

Willems, J. I. A., Bianchi, R., & Tummers-de Lind van Wijngaarden, R. F. A. (2022). [Preference policy for levothyroxine: switch between brands may lead to symptoms and extra costs]. Nederlands Tijdschrift Voor Geneeskunde, 166.

Chicago

Willems, Jeresa I A, Rutgert Bianchi, and Roderick F A Tummers-de Lind van Wijngaarden. 2022. “[Preference Policy for Levothyroxine: Switch between Brands May Lead to Symptoms and Extra Costs].” Nederlands Tijdschrift Voor Geneeskunde 166 (February). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=35138748&authtype=sso&custid=ns315887.